Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Denys

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Current Medical Research and Opinion|May 20, 2006
Improving the global management of the neurogenic bladder patient: part II. Future treatment strategiesPierre Denys, Jacques Corcos, Karel Everaert, et al.
BMC Infectious Diseases|April 17, 2016
Management of febrile urinary tract infection among spinal cord injured patientsAurélien Dinh, Adnène Toumi, Constance Blanc, et al.
Archives of Physical Medicine and Rehabilitation|July 8, 2008
Intermittent positive-pressure breathing effects in patients with high spinal cord injuryIsabelle Laffont, Djamel Bensmail, Sylvie Lortat-Jacob, et al.
Archives of Physical Medicine and Rehabilitation|July 9, 2005
Respiratory effects of combined truncal and abdominal support in patients with spinal cord injuryNicholas Hart, Isabelle Laffont, Annie Perez de la Sota, et al.
Annals of Neurology|December 6, 2016
Human spinal ejaculation generatorClément Chéhensse, Patricia Facchinetti, Stéphane Bahrami, et al.
Toxins|February 24, 2022
BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional StudyJacquie Maignel, Vincent Martin, Rana Assaly, et al.
Neurology|July 22, 2018
Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MSMark Tullman, Emmanuel Chartier-Kastler, Alfred Kohan, et al.
BMC Neurology|July 11, 2013
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening toolDavid Bates, Jack Burks, Denise Globe, et al.
European Urology|October 1, 2008
Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus reportApostolos Apostolidis, Prokar Dasgupta, Pierre Denys, et al.
World Journal of Urology|August 17, 2021
Prioritization of risk situations in neuro-urology: guidelines from Association Française d'Urologie (AFU), Association Francophone Internationale des Groupes d'Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)Claire Hentzen, Xavier Biardeau, Nicolas Turmel, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Current Medical Research and Opinion|May 20, 2006
Improving the global management of the neurogenic bladder patient: part II. Future treatment strategiesPierre Denys, Jacques Corcos, Karel Everaert, et al.
BMC Infectious Diseases|April 17, 2016
Management of febrile urinary tract infection among spinal cord injured patientsAurélien Dinh, Adnène Toumi, Constance Blanc, et al.
Archives of Physical Medicine and Rehabilitation|July 8, 2008
Intermittent positive-pressure breathing effects in patients with high spinal cord injuryIsabelle Laffont, Djamel Bensmail, Sylvie Lortat-Jacob, et al.
Archives of Physical Medicine and Rehabilitation|July 9, 2005
Respiratory effects of combined truncal and abdominal support in patients with spinal cord injuryNicholas Hart, Isabelle Laffont, Annie Perez de la Sota, et al.
Annals of Neurology|December 6, 2016
Human spinal ejaculation generatorClément Chéhensse, Patricia Facchinetti, Stéphane Bahrami, et al.
Toxins|February 24, 2022
BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional StudyJacquie Maignel, Vincent Martin, Rana Assaly, et al.
Neurology|July 22, 2018
Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MSMark Tullman, Emmanuel Chartier-Kastler, Alfred Kohan, et al.
BMC Neurology|July 11, 2013
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening toolDavid Bates, Jack Burks, Denise Globe, et al.
European Urology|October 1, 2008
Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus reportApostolos Apostolidis, Prokar Dasgupta, Pierre Denys, et al.
World Journal of Urology|August 17, 2021
Prioritization of risk situations in neuro-urology: guidelines from Association Française d'Urologie (AFU), Association Francophone Internationale des Groupes d'Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)Claire Hentzen, Xavier Biardeau, Nicolas Turmel, et al.
Pageof 12